Serial changes in bone mineral density and bone turnover after correction of secondary hyperparathyroidism in a patient with pseudohypoparathyroidism type Ib

Journal of Bone and Mineral Research

Volumn 15, Issue 7, 2000, Pages 1412-1416

  Tollin, Steven R ^a,c   Perlmutter, Steven ^b   Aloia, John F ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Bone density; Bone turnover; Pseudohypoparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; CALCIUM ION; COLLAGEN TYPE 1; PARATHYROID HORMONE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE DISEASE; BONE MINERAL; BONE TURNOVER; CASE REPORT; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; MALE; PSEUDOHYPOPARATHYROIDISM; SECONDARY HYPERPARATHYROIDISM;

EID: 0034045765     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.7.1412     Document Type: Article

References (22)

1. Levine MA 1993 Parathyroid hormone resistance syndromes. In: Favus MJ (ed.) Primer on the Metabolic Bone Diseases, 2nd ed. Raven Press, New York, NY, U.S.A., pp. 194-200.
2. Schipani E, Weinstein LS, Bergwitz C, Iida-Klein A, Kong XF, Stuhrmann M, Kruse K, Whyte MP, Murray T, Schmidtke J, van Dop C, Brickman AS, Crawford JD, Potts JT Jr, Kronenberg HM, Abou-Samra AB, Segre GV, Juppner H 1995 Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab 80:1611-1621.
3. Bettoun JD, Minagawa M, Kwan MY, Lee HS, Yasuda T, Hendy GN, Goltzman D, White JH 1997 Cloning and characterization of the promoter regions of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene: Analysis of deoxyribonucleic acid from normal subjects and patients with pseudohypoparathyroidism type 1b. J Clin Endocrinol Metab 82:1031-1040.
4. Juppner H, Schipani E, Bastepe M, Cole DEC, Lawson ML, Mannstadt M, Hendy GN, Plotkin H, Koshiyama H, Koh T, Crawford JD, Olsen BR, Vikkula M 1998 The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci U S A 95:11798-11803.
5. Kidd GS, Schaaf M, Adler R, Lassman MN, Wray HL 1980 Skeletal responsiveness in pseudohypoparathyroidism: A spectrum of clinical disease. Am J Med 68:772-781.
6. Breslau NA, Moses AM, Pak CYC 1983 Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism. J Clin Endocrinol Metab 57:638-644.
7. Murray TM, Rao LG, Wong MM, Waddell JP, Mcbroom R, Tam CS, Rosen F, Levine MA 1993 Pseudohypoparathyroidism with osteitis fibrosa cystica: Direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone. J Bone Miner Res 8:83-91.
8. Giraud P, Audran M, Rohmer V, Jallet P, Basle MF, Bregeon C, Bigorgne JC 1995 Direct effect of calcitriol on the regulation of parathyroid secretion in a case of pseudohypoparathyroidism (a 24-month follow-up study). Clin Rheumatol 14: 287-291.
9. Ish-Shalom S, Rao LG, Levine MA, Fraser D, Kooh SW, Josse RG, McBroom R, Wong MM, Murray TM 1996 Normal parathyroid hormone responsiveness of bone derived cells from a patient with pseudohypoparathyroidism. J Bone Miner Res 11:8-10.
10. Eubanks PJ, Stabile BE 1998 Osteitis fibrosa cystica with renal parathyroid hormone resistance. Arch Surg 133:673-676.
11. Farfel Z 1999 Pseudohypohyperparathyroidism-pseudohypoparathyroidism type Ib. J Bone Miner Res 6:1016.
12. Resnick D, Niwayama G 1995 Parathyroid disorders and renal osteodystrophy. In: Resnick D (ed.) Diagnosis of Bone and Joint disorders, 3rd ed. W.B. Saunders, Philadelphia, PA, U.S.A., pp. 2012-2075.
13. Chase LR, Melson GL, Aurbach GD 1969 Pseudohypoparathyroidism: Defective excretion of 3′5′-AMP in response to parathyroid hormone. J Clin Invest 48:1832-1844.
14. Broadus AE, Mahaffey JE, Bartter FC, Neer RM 1977 Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J Clin Invest 60:771-783.
15. Silverberg SJ, Shane E, Cruz LDL, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV, Lindsay R, Clemens TL, Bilezikian JP 1989 Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4:283-291.
16. Silverberg SJ, Garterberg F, Jacobs TP, Shane E, Siris E, Staron RB, Mcmahon DJ, Bilezikian JP 1995 Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 80:729-734.
17. Garnero P, Ginetys E, Arbault P, Christiansen C, Delmas PD 1994 Different effects of bisphosphonate and estrogen therapy on free and peptide-bound cross-links excretion. J Bone Miner Res 10:641-648.
18. Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD, Greenspan SL 1994 Specificiiy of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int 54:26-29.
19. Bilke DD 1997 Biochemical markers in the assessment of bone disease. Am J Med 103:427-436.
20. Chesnut CH, Bell NH, Clark GS, Drinkwater BL, English SC, Johnston CC Jr, Notelovitz M, Rosen C, Cain DF, Flessland KA, Mallinak JS 1997 Hormone replacement therapy in postmemopausal women: Urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med 102:29-37.
21. Tanaka Y, Funahashi H, Tsuneo I, Tominaga Y, Tanagi H 1997 Parathyroid function and bone metabolic markers in primary and secondary hyperparathyroidism. Semin Surg Oncol 13:125-133.
22. Kamel S, Brazier M, Rogez JC, Vincent O, Maamer M, Desmet G, Serbert JL 1996 Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitaimin D insufficiency. J Clin Endocrinol Metab 81:3717-3721.